# Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS

> **NCT03632187** · PHASE3 · UNKNOWN · sponsor: **University Hospital, Brest** · enrollment: 34 (actual)

## Conditions studied

- Polymyalgia Rheumatica

## Interventions

- **DRUG:** Abatacept
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03632187
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-13
- **Primary completion:** 2021-10-21
- **Final completion:** 2022-07-21
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2022-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03632187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03632187, "Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03632187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*